Vanguard disaggregates holdings; reports 0% in Teladoc Health (NYSE: TDOC)

Rhea-AI Filing Summary

The Vanguard Group filed Amendment No. 10 to a Schedule 13G/A reporting on holdings of Teladoc Health Inc. The filing states amount beneficially owned: 0 and percent of class: 0%, reflecting an internal realignment where certain Vanguard subsidiaries now report separately in reliance on SEC Release No. 34-39538 (January 12, 1998). The filing lists Vanguard's address and certifies that no other single person holds more than 5% of the class. The form is signed by Ashley Grim on 03/27/2026.

Insights

Institutional Ownership Analyst

Vanguard's amendment shows no beneficial ownership of Teladoc after internal disaggregation.

The filing reports 0 shares and 0% beneficial ownership by The Vanguard Group as a result of an internal realignment. The disclosure cites SEC Release No. 34-39538, which permits reporting subsidiaries separately; the change is administrative and traces to organizational reporting rules.

Implications are procedural: subsequent institutional filings may list subsidiary names and nonzero holdings. Future filings should be checked for per-subsidiary positions and any resale activity tied to those accounts.

Corporate Governance Expert

The amendment clarifies voting and dispositive powers are zero following Vanguard's reorganization.

The form explicitly shows sole and shared voting and dispositive power as 0. The narrative explains that certain Vanguard subsidiaries will report beneficial ownership separately and that The Vanguard Group no longer is deemed to beneficially own those subsidiary-held securities under the cited SEC release.

For stakeholders, the key item to watch is follow-on Schedule 13G/A or 13D/A entries from named subsidiaries that may disclose holdings previously aggregated under Vanguard.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/27/2026 - 01:33 PM Learn about SEC filing dates

FAQ

What does Vanguard report for TDOC ownership in this amendment?

Vanguard reports owning 0% of Teladoc Health. The Schedule 13G/A states amount beneficially owned: 0 and voting/dispositive powers of 0, reflecting an internal reporting realignment under SEC Release No. 34-39538.

Why does Vanguard say subsidiaries will report separately for TDOC?

Vanguard cites an internal realignment and SEC Release No. 34-39538. The filing explains certain subsidiaries or business divisions will report beneficial ownership disaggregated from The Vanguard Group, Inc., and pursue the same investment strategies as before the realignment.

Does the filing indicate Vanguard still controls TDOC shares indirectly?

The filing states The Vanguard Group has no beneficial ownership in this Schedule. It also notes that subsidiaries will report separately and that The Vanguard Group no longer is deemed to beneficially own securities held by those subsidiaries per the cited SEC release.

Were any voting or dispositive powers reported by Vanguard for TDOC?

No voting or dispositive powers were reported. The form lists sole voting power, shared voting power, sole dispositive power, and shared dispositive power each as 0, with percent of class shown as 0%.

When was the Schedule 13G/A amendment signed for TDOC?

The filing is signed on 03/27/2026 by Ashley Grim, Head of Global Fund Administration. The amendment is labeled Amendment No. 10 and references the internal realignment effective earlier in January 2026.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 10)

Teladoc Health Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

87918A105

(CUSIP Number)

03/13/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 87918A105

1

Names of Reporting Persons

The Vanguard Group

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

IA

Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Teladoc Health Inc
(b)	Address of issuer's principal executive offices: 2 Manhattanville Road, Suite 203, Purchase, NY, 10577
Item 2.
(a)	Name of person filing: The Vanguard Group
(b)	Address or principal business office or, if none, residence: 100 Vanguard Blvd.,, Malvern, PA, 19355
(c)	Citizenship: PA
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.:
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 0
(b)	Percent of class: 0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The Vanguard Group, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.No one other person's interest in the securities reported herein is more than 5%.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

The Vanguard Group

Signature:	Ashley Grim
Name/Title:	Head of Global Fund Administration
Date:	03/27/2026